CROI 2016: Hot Spots in HIV Infection and Advances in HIV Prevention.
Authors:
- 12 July 2016
- journal article
- review article
- Vol. 24 (1) , 10-28
Abstract
The 2016 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted hot spots in HIV infection. Men who have sex with men (MSM), transgender populations, people who inject drugs, fisherfolk, migrants, adolescents, and older adults are heavily impacted in a number of regions. Stigma contributes to risk behaviors and HIV acquisition across populations. HIV testing is a crucial first step in the HIV care continuum, and several large community-based surveys are underway in Africa to increase HIV testing, linkage to care, and uptake of antiretroviral treatment. Advances in preexposure prophylaxis (PrEP) featured prominently at CROI 2016. Two large efficacy trials of a vaginal ring containing the investigational drug dapivirine demonstrated efficacy and safety in preventing HIV infections in women in Africa. Data on the safety of long-acting injectable PrEP and several investigational PrEP drugs and formulations were also presented. Knowledge and use of PrEP among MSM in the United States appears to be increasing, and high uptake was seen among black MSM when provided as part of a culturally tailored support program. The use of broadly neutralizing antibodies for HIV prevention is a novel and promising approach to be evaluated in efficacy trials.Keywords
This publication has 8 references indexed in Scilit:
- CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016MMWR. Recommendations and Reports, 2016
- Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013JAMA Pediatrics, 2016
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialThe Lancet, 2016
- On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 InfectionNew England Journal of Medicine, 2015
- HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trialThe Lancet HIV, 2015
- Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling, in Children, Adolescents and Adults on Antiretroviral Therapy for HIV in SwazilandPLOS ONE, 2015
- Rates and Correlates of Antiretroviral Therapy Use and Virologic Suppression Among Perinatally and Behaviorally HIV-Infected Youth Linked to Care in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- Worldwide burden of HIV in transgender women: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2013